Cortagen
Cortagen is a Khavinson tetrapeptide studied for neuroprotection, neural regeneration, and gene-expression modulation in nervous-system tissue.
Overview
Cortagen (Ala-Glu-Asp-Pro) is a synthetic tetrapeptide derived from amino-acid analysis of the natural cortex preparation Cortexin and is discussed within the Khavinson bioregulator framework. It is not FDA-approved for any indication.
Preclinical literature describes neuroprotective, regenerative, and epigenetic or gene-expression-modulating effects, but large human controlled trials are not available. This page presents the supplied once-daily subcutaneous protocol as educational content.
At a Glance
Protocol
Suggested once-daily protocol with a two-week ramp to the full dose.
Inject once daily subcutaneously using the 3.0 mL dilution to keep measurements practical on an insulin syringe. The evidence base is primarily preclinical and observational, with nerve-regeneration and neuroprotective outcomes discussed more strongly than broad human efficacy claims.
Dose progression
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
How Cortagen works.
Cortagen is described as a gene-expression-modulating and epigenetic bioregulator peptide derived from cortex tissue analysis. The literature highlights neurotrophic-factor support, oxidative-stress reduction, and accelerated peripheral nerve regeneration in preclinical models.
Animal work in ischemia and nerve-injury models is the main support base. Human evidence is more limited and does not match the depth of the mechanistic discussion.
Effects
Observations from clinical or preclinical literature.
Caution
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
CoFactors
Life Factors
Complementary strategies for best outcomes.
Metrics
Day-to-day metrics worth tracking through the protocol.
- Cognitive performance - track memory, focus, and processing speed trends
- Sleep quality and duration - useful for neurorecovery tracking
- Mood and stress resilience - monitor subjective changes over the cycle
- Injection-site reactions - note redness, swelling, or discomfort
Labs
Baseline and periodic bloodwork to monitor systemic health during the protocol.
Supplies Calculator
Estimates assume the schedule defined for this peptide.
Dose Calculator
Dose Calculator
Preparation
Careful technique preserves potency. Solution should be clear — do not shake.
- Allow vial to reach room temperature for 15–20 minutes before reconstitution.
- Draw the chosen bacteriostatic water volume with a sterile syringe.
- Inject slowly down vial wall; avoid foaming.
- Gently swirl/roll until dissolved (do not shake).
- Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
- Use within 30 days; discard any unused solution after 30 days.
Technique
General subcutaneous guidance from clinical best-practice resources.
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Storage
Notes
Notes
References
- PubMedSciatic-nerve regeneration literature involving Cortagen.https://pubmed.ncbi.nlm.nih.gov/11276314/
- PubMedCortexin and Cortagen work in chronic cerebral ischemia.https://pubmed.ncbi.nlm.nih.gov/21476278/
- Neuroendocrinology Letters / PubMedGene-expression work involving Cortagen in tissue models.https://pubmed.ncbi.nlm.nih.gov/15159690/
- Molecules (MDPI)Systematic review context for peptide regulation of gene expression.https://www.mdpi.com/1420-3049/26/22/7053
- CDCSubcutaneous injection route guidance.https://www.cdc.gov/vaccines/hcp/admin/downloads/YCTS-VaxAdmin-Subcut-injection.pdf
- WHO (NCBI Bookshelf)Injection-safety guidance for subcutaneous administration.https://www.ncbi.nlm.nih.gov/books/NBK390474/